OverviewChartNewsTraderScreen

DZ Bank Knock-Out AMG/  DE000DW7PGN1  /

Frankfurt Zert./DZB
2/3/2023  7:34:19 PM Chg.+0.150 Bid8:01:39 PM Ask8:01:39 PM Underlying Strike price Expiration date Option type
5.170EUR +2.99% 5.220
Bid Size: 10,000		 5.230
Ask Size: 10,000		 AMGEN INC. DL-... 298.9121 - 12/31/2078 Put
TeleTrader 2/1 Dow dips 200 pts at open as markets brace for Fed guidance
TeleTrader 1/31 Amgen: Net income down 15% in Q4 to $1.6 billion
TeleTrader 1/31 Dow up by 200 pts ahead of interest rate decision
TeleTrader 12/12/2022 US stocks end strong day, Dow up over 500 pts
TeleTrader 12/12/2022 US kicks off with gains as markets brace for rate hikes
TeleTrader 12/12/2022 Amgen to buy Horizon for $26.4 billion
TeleTrader 12/11/2022 Amgen close to buying Horizon, worth over $20B - report
TeleTrader 11/8/2022 US stocks close higher amid midterm elections
TeleTrader 11/8/2022 US stocks rally as markets brace for midterm elections
TeleTrader 11/4/2022 US opens higher after nonfarm payrolls report
TeleTrader 11/3/2022 Amgen sees EPS soaring 20% to $3.98 in Q3
TeleTrader 11/3/2022 US closes lower ahead of another batch of earnings
TeleTrader 11/3/2022 Wall Street opens lower after Fed hikes rate again
TeleTrader 10/24/2022 US closes higher with major earnings reports in focus
TeleTrader 10/24/2022 Wall Street extends gains, Dow soars 500 points
TeleTrader 10/24/2022 US markets open mostly higher amid earnings releases
TeleTrader 10/19/2022 Dow falls 250 pts as Wall Street changes course again
TeleTrader 10/11/2022 Wall Street closes mostly lower after BoE warning
TeleTrader 8/31/2022 US opens higher with economy in focus
TeleTrader 8/4/2022 Amgen's Q2 EPS triples to $2.45
TeleTrader 8/4/2022 US closes mostly lower after labor market data
TeleTrader 8/4/2022 US opens mostly flat after trade, jobs data
TeleTrader 6/2/2022 Wall Street opens lower amid data
GlobeNewswire 3/23/2022 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire 3/23/2022 OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...